HLA-alleles associated with increased risk for extra-pulmonary involvement in sarcoidosis

Tissue Antigens

Volumn 83, Issue 4, 2014, Pages 267-272

  Darlington, P ^a,b   Gabrielsen, A ^a   Sorensson P ^a   Tallstedt, L ^c   Padyukov, L ^d   Eklund, A ^a   Grunewald, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

^c ST ERIK S EYE HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Extra pulmonary involvement; Human leukocyte antigen; L fgren's syndrome; Sarcoidosis

Indexed keywords

HLA DRB1 ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BONE MARROW DISEASE; CHILD; CONTROLLED STUDY; EYE DISEASE; FEMALE; GENETIC RISK; HEART DISEASE; HISTOCOMPATIBILITY GENE; HLA DRB1 GENE; HLA TYPING; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; KIDNEY DISEASE; LIVER DISEASE; LOFGREN SYNDROME; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROLOGIC DISEASE; PAROTID GLAND DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SALIVARY GLAND DISEASE; SARCOIDOSIS; SCHOOL CHILD; SKIN DISEASE; SPLEEN DISEASE; YOUNG ADULT;

EXTRA-PULMONARY INVOLVEMENT; HUMAN LEUKOCYTE ANTIGEN; LÖFGREN'S SYNDROME; SARCOIDOSIS;

ADOLESCENT; ADULT; AGED; ALLELES; CHILD; FEMALE; HISTOCOMPATIBILITY TESTING; HLA-DRB1 CHAINS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SARCOIDOSIS; SWEDEN;

EID: 84896297611     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12326     Document Type: Article

References (30)

1. Iannuzzi MC, Rybicki BA, Teirstein AS. Medical progress: sarcoidosis. N Engl J Med 2007: 357: 2153-65.
2. Rudensky AY, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA. Sequence analysis of peptides bound to MHC class II molecules. Nature 1991: 353: 622-7.
3. Grunewald J, Eklund A. Lofgren's syndrome human leukocyte antigen strongly influences the disease course. Am J Resp Crit Care Med 2009: 179: 307-12.
4. Grunewald J, Berlin M, Olerup O, Eklund A. Lung T-helper cells expressing T-cell receptor AV2S3 associate with clinical-features of pulmonary sarcoidosis. Am J Respir Crit Care Med 2000: 161: 814-8.
5. Grunewald J, Shigematsu M, Nagai S et al. T-cell receptor V gene expression in HLA-typed Japanese patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1995: 151: 151-6.
6. Sato H, Woodhead FA, Ahmad T et al. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet 2010: 19: 4100-11.
7. Hunninghake GW, Costabel U, Ando M et al. Statement on sarcoidosis. Am J Respir Crit Care Med 1999: 160: 736-55.
8. Darlington P, Tallstedt L, Padyukov L et al. HLA-DRB1* alleles and symptoms associated with Heerfordt's syndrome in sarcoidosis. Eur Respir J 2011: 38: 1151-7.
9. Herbort CP, Rao NA, Mochizuki M. Sarcoidosis moSCoFIWoO. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop on Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm 2009: 17: 160-9.
10. Hiraga H, Hiroe M, Iwai K. Guideline for Diagnosis of Cardiac Sarcoidosis: Study Report on Diffuse Pulmonary Diseases(in Japanese). Tokyo: The Japanese Ministry of Health and Welfare, 1993, 23-4.
11. Zajicek JP, Scolding NJ, Foster O et al. Central nervous system sarcoidosis - diagnosis and management. QJM 1999: 92: 103-17.
12. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and HLA-DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993: 41: 119-34.
13. Kockum I, Sanjeevi CB, Eastman S, Landin-Olsson M, Dahlquist G, Lernmark A. Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes. Eur J Immunogenet 1999: 26: 361-72.
14. Sanjeevi CB, Lybrand TP, DeWeese C et al. Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of IDDM. Members of the Swedish Childhood Diabetes Study. Diabetes 1995: 44: 125-31.
15. Martinetti M, Tinelli C, Kolek V et al. "The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med 1995: 152: 557-64.
16. Wennerström A, Pietinalho A, Vauhkonen H et al. HLA-DRB1 allele frequencies and C4 copy number variation in Finnish sarcoidosis patients and associations with disease prognosis. Hum Immunol 2012: 73: 93-100.
17. Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 2002: 31: 355-60.
18. Sawcer S, Hellenthal G, Pirinen M et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011: 476: 214-9.
19. Mira MT. Genetic host resistance and susceptibility to leprosy. Microbes Infect 2006: 8: 1124-31.
20. Grosser M, Luther T, Fuessel M, Bickhardt J, Magdolen V, Baretton G. Clinical course of sarcoidosis in dependence on HLA-DRB1 allele frequencies, inflammatory markers, and the presence of M. tuberculosis DNA fragments. Sarcoidosis Vasc Diffuse Lung Dis 2005: 22: 66-74.
21. Chen ES, Wahlstrom J, Song ZM et al. T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol 2008: 181: 8784-96.
22. Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996: 59: 1134-48.
23. Baughman RP, Culver DA, Judson MA. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med 2011: 183: 573-81.
24. Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004: 169: 696-702.
25. Grubić Z, Zunec R, Peros-Golubicić T et al. HLA class I and class II frequencies in patients with sarcoidosis from Croatia: role of HLA-B8, -DRB1*0301, and -DQB1*0201 haplotype in clinical variations of the disease. Tissue Antigens 2007: 70: 301-6.
26. Spagnolo P, Grunewald J. Recent advances in the genetics of sarcoidosis. J Med Genet 2013: 50: 290-7.
27. Dubaniewicz A, Zimmermann A, Dudziak M, Typiak M, Skotarczak M. Tuberculosis in the course of sarcoidosis treatment: is genotyping necessary for personalized therapy? Expert Rev Clin Immunol 2013: 9: 349-60.
28. Iannuzzi MC, Fontana JR. Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics. JAMA 2011: 305: 391-9.
29. Chen ES, Moller DR. Medscape. Sarcoidosis - scientific progress and clinical challenges. Nat Rev Rheumatol 2011: 7: 457-67.
30. Warshauer DM, Dumbleton SA, Molina PL, Yankaskas BC, Parker LA, Woosley JT. Abdominal CT findings in sarcoidosis: radiologic and clinical correlation. Radiology 1994: 192: 93-8.